Fundz

Vaccinex Announces Pricing of $3.7 Million PIPE Financing

PUBLIC · VCNXFeb 08, 2024

Amount Raised

$3.7 Million

Round Type

Seed

City Of RochesterBiotechnologyHealthcareHealth CareTherapeutics

Investors

The Company’s Chief Executive OfficerEntities Affiliated With The Chairman Of The Company’s Board Of Directors

Description

Vaccinex, Inc. announced the pricing of a $3.7 million private placement financing with a lead investment from a major new investor alongside significant participation from existing investors. The proceeds from the offering, together with other commitments, will fully fund its ongoing SIGNAL-AD trial through the release of topline data, which is anticipated in the third quarter of 2024.

Quick answer

Vaccinex raised $3.7 Million in a Seed round, dated February 8, 2024. Investors: The Company’s Chief Executive Officer and Entities Affiliated With The Chairman Of The Company’s Board Of Directors. Vaccinex is based in City Of Rochester, New York, United States.

How much did Vaccinex raise?
Vaccinex raised $3.7 Million in a Seed round on February 8, 2024.
Who invested in Vaccinex?
The Company’s Chief Executive Officer and Entities Affiliated With The Chairman Of The Company’s Board Of Directors are named as investors in this round.
What does Vaccinex do?
Vaccinex, Inc. is a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative diseases and cancer through the inhibition of semaphorin 4D (SEMA4D).
Where is Vaccinex based and how big is it?
Vaccinex is based in City Of Rochester, New York, United States.
Who are the decision-makers at Vaccinex?
Fundz holds 1 contact at Vaccinex. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Vaccinex that raised within 45 days of this round, from Fundz verified event records.

  • AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
  • Enliven Therapeutics raised $90M on March 21, 2024.
  • Enliven Therapeutics raised $90M (Post-IPO Equity) on March 20, 2024.
  • NewcelX raised $1.8M (Seed) on March 20, 2024.
  • Tessera Defense & Homeland Security Inc. raised $62M on March 15, 2024.
  • Azora Therapeutics, Inc. (DE) raised $288K (Seed) on March 6, 2024.

Who to call at Vaccinex, and when

A new round usually means Vaccinex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vaccinex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vaccinex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vaccinex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vaccinex

Location

City Of Rochester, New York, United States

About

Vaccinex, Inc. is a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative diseases and cancer through the inhibition of semaphorin 4D (SEMA4D). The Company’s lead drug candidate, pepinemab, a SEMA4D blocking antibody, inhibits damaging inflammation and loss of homeostatic functions in the brain of patients with neurodegenerative diseases and promotes effective tumor immunity in multiple cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vaccinex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts57 people are listed at Vaccinex. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vaccinex's next move

See what Strategic adds

Vaccinex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.